Flag of the United StatesAmerican Chemical Independence

Dexamethasone sodium phosphate

Drug ingredientActive Shortage

CAS 2392-39-4

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 2392-39-4
2 Na⁺
US productionNot reported
Import value, 2024$1.1B
Top sourceSingapore 82%

This chemical is listed as active in US commerce, but no company reported it to EPA’s survey for 2019 or 2023. Sites may have made or imported less than the threshold amount, or none.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293722 · basket

These shares come from HS customs code 293722, which covers 36 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
SG 82%SingaporeGB 15%United KingdomIT 2%Italy
38 FDA-registered drug labelers
A-S Medication Solutions
Advanced Rx of Tennessee, LLC
Advanced Rx Pharmacy of Tennessee, LLC
Amneal Pharmaceuticals LLC
Armas Pharmaceuticals
Asclemed USA, Inc.
Bausch & Lomb Incorporated
Cardinal Health 107, LLC
Civica, Inc.
Curia Spain S.A.U.
Eugia US LLC
EUROAPI FRANCE
Farmabios S.p.A.
Fresenius Kabi USA, LLC
Galenova Inc
Gland Pharma Limited
HENAN LIHUA PHARMACEUTICAL CO., LTD
Henry Schein, Inc.
HF Acquisition Co LLC, DBA HealthFirst
Hikma Pharmaceuticals USA Inc.
Medical Purchasing Solutions, LLC
Medisca Inc.
Micro Labs Limited
Mylan Institutional LLC
NEWCHEM SPA
Pharmacia and Upjohn Company LLC
Phlow Corporation
Professional Compounding Centers of America
Professional Compounding Centers of America dba PCCA
ProPharma Distribution
REMEDYREPACK INC.
Sagent Pharmaceuticals
Somerset Therapeutics, LLC
Sportpharm LLC
Sportpharm, Inc. dba Sportpharm
SYMBIOTICA SPECIALITY INGREDIENTS SDN.BHD
Tianjin Tianyao Pharmaceuticals Co., Ltd.
zhejiang xianju pharmaceutical co., Ltd.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

  • •Dexamethasone Sodium Phosphate
  • •DMT SUIK
FDA Shortage Status
Active Shortage
Shortage History
  • Current shortage

    Dexamethasone Sodium Phosphate Injection

    Shortage listed since February 8, 2019

    Manufacturer reports: 1 unavailable, 1 available

See all current drug shortages

Vendor Pricing

$39.00/gApexbio Technology LLC
CountryUnited States
Pack$195.00 / 5 g
Purity99.72%
Vendors1 available

Prices reflect listed pack sizes. Small research packs run far above bulk rates.

Chemical Identity

CAS2392-39-4
PubChem CID16961
DTXSIDDTXSID3047429
FormulaC22H28FNa2O8P
Mol. Weight516.4 g/mol
SMILESCC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]

Data Sources

← Back to Dashboard← Back to Health

Brief citations

Dexamethasone sodium phosphate (CAS 2392-39-4) https://chemicalindependence.com/chemical/2392-39-4/ PubChem: 16961. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/16961 EPA TSCA Inventory: CAS 2392-39-4. Retrieved 2026-04-24. https://www.epa.gov/tsca-inventory FDA Drug Shortages: CAS 2392-39-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293722 for CAS 2392-39-4. Reporting year: 2024. https://usatrade.census.gov/